Breaking News Instant updates and real-time market news.

SGYP

Synergy Pharmaceuticals

$4.74

-0.07 (-1.46%)

16:34
12/22/16
12/22
16:34
12/22/16
16:34

Synergy reports 'positive' top-line results from Phase 3 plecanatide trial

Synergy Pharmaceuticals announced positive top-line results from the second of two pivotal phase 3 clinical trials evaluating the efficacy and safety of plecanatide, an investigational once-daily orally-administered compound, in 1,054 adult patients with irritable bowel syndrome with constipation. Preliminary analysis of the data indicates that both plecanatide 3 mg and 6 mg doses met the study's primary endpoint and showed statistical significance in the percentage of patients who were Overall Responders compared to placebo during the 12-week treatment period. The most common adverse event was diarrhea which occurred in 5.4% of patients in 3 mg and 4.3% of patients in 6 mg dose groups compared to 0.6% of placebo-treated patients. "We are understandably very pleased with these results, and how well the data support the first pivotal phase 3 IBS-C trial which we announced recently," said Gary S. Jacob, Ph.D., Chairman and CEO of Synergy Pharmaceuticals Inc. "We have been relentless in our commitment to develop innovative treatments for the GI market. The successful phase 3 trials are a major step in our mission to better serve patients, as we believe plecanatide has the potential to be an important new treatment option for the millions of people suffering from IBS-C. I want to, in particular, acknowledge my colleagues at Synergy, my outstanding board, and the many stakeholders who have supported us throughout this clinical program." Synergy reported positive top-line data in the first phase 3 IBS-C trial with plecanatide earlier this month. The company plans to present further clinical data from both trials at an appropriate scientific meeting next year. Additionally, plecanatide is under review by the Food and Drug Administration for the treatment of chronic idiopathic constipation and the Prescription Drug User Fee Act target action date is January 29, 2017. Pending approval in the CIC indication, the company plans to file a New Drug Application Supplement with Clinical Data for plecanatide in IBS-C in Q1 2017.

  • 29

    Jan

SGYP Synergy Pharmaceuticals
$4.74

-0.07 (-1.46%)

09/14/16
09/14/16
NO CHANGE

Citi calls Synergy Pharmaceuticals a potential target for Takeda
09/14/16
SBSH
09/14/16
NO CHANGE
Target $4
SBSH
Neutral
Citi views Synergy Pharmaceuticals as potential target for Takeda
Citi analyst Liav Abraham calls Synergy Pharmaceuticals (SGYP) the most likely potential target for Takeda Pharmaceutical (TKPYY) among her coverage universe. The Financial Times earlier today reported that Takeda is ready to spend as much as $15B in acquisitions to expand its business in the United States. Abraham has a Neutral rating on Synergy with a $4 price target. The analyst sees Synergy as a potential target given the "extensive resources" needed to commercialize its lead asset, plecanatide, as well as Takdea's presence in the irritable bowel syndrome/chronic idiopathic constipation space. Shares of Synergy are up 6% to $5.18 in early trading.
12/12/16
SBSH
12/12/16
NO CHANGE
Target $6.5
SBSH
Neutral
Positive data likely to increase Synergy takeout speculation, says Citi
Citi analyst Liav Abraham believes the positive headline data announced Friday for Synergy Pharmaceuticals' first trial for plecanatide in its second indication, irritable bowel syndrome-constipation, is likely to increase speculation of a takeover. The analyst, however, believes the stock is fully valued at current levels on a stand-alone basis. She views Synergy as a potential takeout target for a larger pharma company and upped her price target for the shares to $6.50 from $4. Abraham keeps a Neutral rating on Synergy.

TODAY'S FREE FLY STORIES

YPF

YPF

$20.14

0.28 (1.41%)

10:55
08/22/17
08/22
10:55
08/22/17
10:55
Options
YPF put volume heavy and directionally bearish »

Bearish flow noted in YPF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCO

Columbus McKinnon

$30.54

-0.29 (-0.94%)

10:52
08/22/17
08/22
10:52
08/22/17
10:52
Conference/Events
Columbus McKinnon management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 29

    Aug

  • 29

    Nov

  • 30

    Nov

BRK.A

Berkshire Hathaway

$269,830.00

1290 (0.48%)

, BRK.B

Berkshire Hathaway

$179.30

0.96 (0.54%)

10:44
08/22/17
08/22
10:44
08/22/17
10:44
Hot Stocks
S&P removes Berkshire Hathaway from CreditWatch, calls outlook 'stable' »

S&P Global Ratings…

BRK.A

Berkshire Hathaway

$269,830.00

1290 (0.48%)

BRK.B

Berkshire Hathaway

$179.30

0.96 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$23.78

0.4 (1.71%)

10:40
08/22/17
08/22
10:40
08/22/17
10:40
Options
Bank of America calls active as shares see strength »

Bank of America calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:40
08/22/17
08/22
10:40
08/22/17
10:40
General news
Treasury Option Action: a build-up of bullish call butterflies »

Treasury Option Action: a…

WILC

G. Willi-Food

$6.49

-0.0209 (-0.32%)

10:35
08/22/17
08/22
10:35
08/22/17
10:35
Hot Stocks
G. Willi-Food names Zwi Williger as co-chairman »

G. Willi-Food…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVG

Pretium Resources

$8.37

-0.18 (-2.11%)

10:35
08/22/17
08/22
10:35
08/22/17
10:35
Options
Pretium Resources put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
08/22/17
08/22
10:35
08/22/17
10:35
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

MDT

Medtronic

$81.88

-1.645 (-1.97%)

, DXCM

Dexcom

$73.06

-0.14 (-0.19%)

10:34
08/22/17
08/22
10:34
08/22/17
10:34
Recommendations
Medtronic, Dexcom, TNDM analyst commentary  »

Medtronic challenges in…

MDT

Medtronic

$81.88

-1.645 (-1.97%)

DXCM

Dexcom

$73.06

-0.14 (-0.19%)

TNDM

TNDM

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 22

    Aug

  • 06

    Sep

  • 07

    Sep

  • 20

    Sep

TWX

Time Warner

$101.67

-0.44 (-0.43%)

, T

AT&T

$37.63

0.045 (0.12%)

10:34
08/22/17
08/22
10:34
08/22/17
10:34
Periodicals
Time Warner-AT&T deal questioned by Brazil regulator, Bloomberg says »

Brazils antitrust…

TWX

Time Warner

$101.67

-0.44 (-0.43%)

T

AT&T

$37.63

0.045 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

FCX

Freeport McMoRan

$15.37

0.6399 (4.34%)

10:32
08/22/17
08/22
10:32
08/22/17
10:32
Technical Analysis
Technical View: Freeport McMoRan breaks through top of recent range »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$18.92

3.23 (20.59%)

10:32
08/22/17
08/22
10:32
08/22/17
10:32
Downgrade
DSW rating change  »

DSW downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

RDFN

Redfin

$27.56

0.86 (3.22%)

, EGN

Energen

$50.21

0.65 (1.31%)

10:29
08/22/17
08/22
10:29
08/22/17
10:29
Initiation
On The Fly: Top five analyst initiations »

Catch up on the…click here.

RDFN

Redfin

$27.56

0.86 (3.22%)

EGN

Energen

$50.21

0.65 (1.31%)

PXD

Pioneer Natural

$128.63

0.69 (0.54%)

RVNC

Revance

$22.70

-0.45 (-1.94%)

PCRX

Pacira

$35.75

-0.05 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 06

    Sep

  • 25

    Sep

  • 02

    Nov

MYL

Mylan

$30.44

-0.28 (-0.91%)

, BIP

Brookfield Infrastructure

$44.78

0.135 (0.30%)

10:29
08/22/17
08/22
10:29
08/22/17
10:29
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

MYL

Mylan

$30.44

-0.28 (-0.91%)

BIP

Brookfield Infrastructure

$44.78

0.135 (0.30%)

GMRE

Global Medical REIT

$8.38

-0.6 (-6.68%)

NXTM

NxStage Medical

$29.11

-0.14 (-0.48%)

FMS

Fresenius Medical

$46.69

0.37 (0.80%)

HKMPY

Hikma

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 03

    Sep

  • 06

    Sep

  • 08

    Sep

  • 15

    Sep

  • 09

    Oct

BABA

Alibaba

$171.47

2.22 (1.31%)

, VMW

VMware

$98.97

1.96 (2.02%)

10:29
08/22/17
08/22
10:29
08/22/17
10:29
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

BABA

Alibaba

$171.47

2.22 (1.31%)

VMW

VMware

$98.97

1.96 (2.02%)

AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

EL

Estee Lauder

$106.53

0.05 (0.05%)

TPX

Tempur Sealy

$62.42

0.91 (1.48%)

WUBA

58.com

$63.80

-0.34 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 27

    Aug

FEYE

FireEye

$13.77

-0.21 (-1.50%)

10:25
08/22/17
08/22
10:25
08/22/17
10:25
Options
FireEye call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 11

    Sep

  • 19

    Sep

VMW

VMware

$99.09

2.08 (2.14%)

, AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

10:23
08/22/17
08/22
10:23
08/22/17
10:23
Hot Stocks
Deutsche ups VMware on slower than expected enterprise move to public cloud »

Deutsche Bank upgraded…

VMW

VMware

$99.09

2.08 (2.14%)

AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

MSFT

Microsoft

$72.15

-0.34 (-0.47%)

ORCL

Oracle

$49.11

0.205 (0.42%)

RHT

Red Hat

$102.19

-0.465 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 27

    Aug

  • 05

    Sep

TWX

Time Warner

$101.80

-0.31 (-0.30%)

, T

AT&T

$37.77

0.1899 (0.51%)

10:21
08/22/17
08/22
10:21
08/22/17
10:21
Periodicals
Time Warner, AT&T deal questioned by Brazil antitrust agency, Bloomberg says »

Shares of Time Warner…

TWX

Time Warner

$101.80

-0.31 (-0.30%)

T

AT&T

$37.77

0.1899 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

SHLD

Sears

$8.55

-0.1 (-1.16%)

, AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

10:19
08/22/17
08/22
10:19
08/22/17
10:19
Hot Stocks
Sears jumps after announcing latest licensing deals for Kenmore, DieHard brands »

Shares of Sears Holdings…

SHLD

Sears

$8.55

-0.1 (-1.16%)

AMZN

Amazon.com

$953.29

-5.18 (-0.54%)

LOW

Lowe's

$75.27

1.42 (1.92%)

HD

Home Depot

$150.33

1.13 (0.76%)

BBY

Best Buy

$61.37

0.9185 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 23

    Aug

  • 24

    Aug

  • 24

    Aug

  • 29

    Aug

  • 19

    Sep

  • 21

    Nov

$NSD

NASDAQ Market Internals

10:17
08/22/17
08/22
10:17
08/22/17
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PULM

Pulmatrix

$1.67

-0.03 (-1.76%)

10:16
08/22/17
08/22
10:16
08/22/17
10:16
Hot Stocks
Pulmatrix patent for respirable tiotropium dry powders posted to USPTO site 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

10:16
08/22/17
08/22
10:16
08/22/17
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
08/22/17
08/22
10:15
08/22/17
10:15
General news
U.S. Richmond Fed manufacturing index was flat at 14 in August »

U.S. Richmond Fed…

AVGO

Broadcom

$249.62

0.25 (0.10%)

10:10
08/22/17
08/22
10:10
08/22/17
10:10
Options
Bullish option play in Broadcom ahead of earnings »

Bullish option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

CARB

Carbonite

$19.10

-0.15 (-0.78%)

10:05
08/22/17
08/22
10:05
08/22/17
10:05
Hot Stocks
Carbonite annonces strategic referral deal with Code42 »

Carbonite announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.